Cues
Boehringer boards B-cell depletion bandwagon, paying Cue $12M to line up autoimmune attack
Cues, CUE-501, B-Lymphocytes, Boehringer, Depletion, paying, T-Lymphocyte
Biopharma Layoff Tracker 2024: FibroGen, Pfizer, Cue, and More Cut Staff
Biopharma layoffs, FibroGen, Pfizer, Cue, Anokion, biotech industry, job cuts, restructuring initiatives